Menopause and the Heart

Chileshe Nkonde-Price; Jeffrey R Bender

doi:10.1016/j.ecl.2015.05.005

Menopause and the Heart

Endocrinol Metab Clin North Am. 2015 Sep;44(3):559-64. doi: 10.1016/j.ecl.2015.05.005. Epub 2015 Jun 22.

Authors

Chileshe Nkonde-Price¹, Jeffrey R Bender²

Affiliations

¹ Penn Heart and Vascular Center for Women's Cardiovascular Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
² Section of Cardiovascular Medicine, Yale Cardiovascular Research Center, Raymond and Beverly Sackler Cardiovascular Laboratory, Yale University School of Medicine, 300 George Street, Room 773G, New Haven, CT 06511, USA. Electronic address: jeffrey.bender@yale.edu.

PMID: 26316243
DOI: 10.1016/j.ecl.2015.05.005

Abstract

Cardiovascular disease is the leading cause of death in postmenopausal US women. The contribution of postmenopausal hormone replacement therapy to cardiovascular risk is one of the most controversial women's health topics. Strikingly discordant results, between observational and randomized clinical trials, have been reported. Remaining questions regarding time of hormone therapy initiation are discussed, as are ongoing trials focused on these questions. Cardiovascular concerns, cautions, and current recommendations for use are delineated.

Keywords: Cardiovascular risk; Heart; Hormone replacement therapy; Menopause.

Publication types

Review

MeSH terms

Cardiovascular Diseases / prevention & control*
Estrogen Replacement Therapy*
Female
Humans
Postmenopause / drug effects*
Risk Assessment
Risk Factors
Women's Health